Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Facebook Inc. (FB): Director’s Stock Sale Mean Anything?

Page 1 of 2

Facebook Inc. (NASDAQ:FB) has been rising since it bottomed out at $18 a share in the fall, recovering my nearly 60 percent since – even with a couple of lockup expirations in the last several months, which were supposedly flooding the market with newly tradable shares. However, one report focuses on the methodical selling of shares by a single member of the company’s board of directors, Jim Breyer.

Facebook Inc. (FB)

Over the course of the last eight months – since the IPO in mid-May – Breyer sold about $205 million in shares. And this single individual, who sold his shares over a longer period of time – instead of within a month or a few weeks – is drawing some attention from several outsiders. The thrust of the discussion in the article published by Financial Times revolved around whether it’s a conflict of interest or ethical to be a member of the board of directors of a company and sell shares.

“Board members should never sell,” said Charles Elson, corporate-governance professor at the University of Delaware. “It’s like being a Congressman going for election, then renouncing his citizenship but wishing to remain in Congress.”

On the whole, since the IPO, senior Facebook Inc. (NASDAQ:FB) executives have sold 43 million shares for a total value of $1.5 billion, which actually represents about 4 percent of the total outstanding shares. Breyer’s sales were the largest amount by a senior executive that was for personal gain and had gone virtually ignored – until now. He has sold 6.8 million of his 11.7-million-share allotment at the time of the IPO.

“Everyone understands that having all your eggs in one basket is not a prudent financial strategy,” said David Yoffie, professor at the Harvard Business School. “But you have to balance that against perceptions that you’re abandoning your faith in the company by selling a significant shareholding.”

But is Breyer’s sale of Facebook Inc. (NASDAQ:FB) stock abnormal?

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!